Tonix Pharmaceuticals Holding Forum: Community User: StefanN19

Tonix expects small animal and non-human primate data from safety studies of TNX-1800 in COVID-19 models to measure safety and the immune response to the SARS-COV-2 Spike protein in the fourth quarter of 2020. In addition, we also expect data from non-human primate studies to measure efficacy in challenge studies using SARS-COV-2 in the fourth quarter.

The second quarter was highlighted by exciting progress for our lead immunology and central nervous system product candidates,” said Seth Lederman, M.D., President and Chief Executive Officer. “We expect to have the first data from animal studies of our lead COVID-19 vaccine candidate, TNX-1800, in the fourth quarter of this year. TNX-1800 is a live attenuated vaccine based on our proprietary horsepox vector system that carries a gene encoding the Spike protein from SARS-CoV-2, the virus that causes COVID-19. We have also continued to progress the Phase 3 RELIEF study of TNX-102 SL for fibromyalgia, having reached 50% enrollment in April and then completing enrollment in July, ahead of schedule. We look forward to interim data in September and topline results from the RELIEF study by the end of this year.”

https://ir.tonixpharma.com/press-releases/detail/1222

News (Update) sind da von heute ✌️

Big Player hier 😎😎

Real Markus.... das halte ich mal für nicht ernst

Hast ja zum Glück noch ein paar Milliarden an der Seite liegen 🤣

Bin derzeit 40 tsd im minus mit tonix

Ich dachte die Zahlen komnen am 21.8

Ja bleib weiter

So wie ich es gelesen habe sind am 17.08. die Quartalszahlen!!!

Da wird noch was gutes kommen an News. Die müssen über 1$ bleiben.

Earnings Announcement before market open - steht bei CNBC

Aussitzen. Dem schließe ich mich an

Ich bleibe drin

Bin jetzt auch im Minus Aber Gegenbewegung kommt wieder, hoffe ich zumindest